missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant Human beta-Defensin 3 Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
Brand: R&D Systems™ 4435-BD-050
This item is not returnable.
View return policy
Description
Measured by its anti-microbial activity against E. coli. Ganz, T. et al. (2003) Nat. Rev. Immunol. 3:710. The ED50 for this effect is 7.5-30 μg/mL.Specifications
| P81534 | |
| Lyophilized from a 0.2 μm filtered solution in HCl. | |
| M.W. (theoretical): 5.2 kDa | |
| 50 μg | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, -20°C to -70°C under sterile conditions after reconstitution. | |
| DEFB103B | |
| Recombinant | |
| >95%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
| Bioactivity | |
| 55894 | |
| beta-Defensin 3 | |
| E. coli-derived human beta-Defensin 3 protein Gly23-Lys67 | |
| <0.01 EU / 1 μg of the protein by the LAL method. | |
| Unconjugated | |
| Reconstitute at 500 μg/mL in sterile 4 mM HCl. | |
| beta-Defensin 3 |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction